Fructus chebulae extract, preparation method thereof and application of fructus chebulae extract in weaned piglet feed capable of completely replacing zinc oxide

By preparing efficient oxalis extract, zinc oxide is solved in the environmental pollution and health risks in weaned piglet feed, and a complete replacement of zinc oxide is achieved, which significantly improves the growth performance and intestinal health of piglets.

CN118901889AInactive Publication Date: 2024-11-08WUXI ZHENGDA POULTRY
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411089616.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the prior art, the use of zinc oxide in feed for weaned piglets has environmental pollution and health risks, and its substitutes have not yet been completely replaced, which cannot effectively reduce piglet diarrhea and improve growth performance.

Method used

Using oxalus extract as a substitute, efficient oxalus extract is prepared through pulverization, soaking, extraction, negative pressure concentration and drying processes, which are used to completely replace zinc oxide and improve the growth performance and intestinal health of piglets.

Benefits of technology

The extract of ferrophoresis is significantly better than zinc oxide in in vitro and animal experiments, with strong antibacterial effects, which improves the growth performance and intestinal health of piglets, and is environmentally friendly, achieving a complete replacement of zinc oxide.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118901889A_ABST
    Figure CN118901889A_ABST
Patent Text Reader

Abstract

The invention relates to a fructus chebulae extract, a preparation method thereof and application of the fructus chebulae extract in a weaned piglet feed capable of completely replacing zinc oxide. The production method of the fructus chebulae extract comprises the following process steps: pretreatment, extraction, filtration, concentration and drying. The fructus chebulae extract prepared by the method can be added into weaned piglet feed to completely replace zinc oxide, so that not only can the intestinal health and growth performance of piglets be improved, but also the problem that zinc oxide is discharged from excrement to pollute the environment can be avoided, and the problems that zinc oxide antagonizes absorption of other trace elements and causes disordered fur and hair of the piglets and the like can be solved; therefore, the method has important practical significance and great social value. Meanwhile, the medicine terminalia fruit extract can also be widely applied to production of antibiotic-free feed, the used raw material medicine terminalia fruit is a typical traditional Chinese medicine and can be widely planted, large-scale use of the medicine terminalia fruit extract in animal husbandry is also beneficial to agricultural economic development, and the medicine terminalia fruit extract has high economic value. Therefore, large-scale popularization and application are worthy.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of feed and feed additives, in particular to a terminalia chebula extract and a preparation method thereof and application thereof in weaned piglet feed which can completely replace zinc oxide. Background Art

[0002] The survival rate of piglets is an important indicator to measure the efficiency and management level of a pig farm. Due to changes in diet and environment, piglets are most likely to suffer from a series of intestinal health problems such as diarrhea, which leads to an increase in mortality. How to reduce the mortality rate of piglets is one of the urgent problems that the breeding industry needs to solve. At present, the use of high-dose zinc oxide in weaned piglet feed to control diarrhea is a common method adopted by farms. Zinc oxide has been proven to increase piglet feed intake, daily weight gain, feed conversion efficiency, and effectively reduce the incidence of diarrhea in piglets. Although the effect is good, the disadvantages are also obvious. One is the impact on the environment, and the other is the impact on the suckling piglets themselves. Therefore, the EU will completely ban the use of zinc oxide in breeding in June 2022. For the sake of human health, it is not expected that China will ban zinc oxide for too long. Therefore, finding a feed additive that can completely replace zinc oxide has important practical significance and social value.

[0003] In the research on zinc oxide replacement, the research and application of Chinese herbal medicine extracts are the focus of national support due to their safety and effectiveness. As a tannin with similar pharmacological effects to zinc oxide, terminalia chebula extract can be used as a first choice to replace zinc oxide for controlling animal diarrhea. Terminalia chebula extract not only has excellent antibacterial and antioxidant properties, but also can improve the growth rate and immunity of weaned piglets. At the same time, terminalia chebula extract is derived from natural plants, is non-toxic, has no bad odor, does not pollute the environment, and conforms to the modern green and environmentally friendly production concept. At present, there has been no in-depth research and industrial application of terminalia chebula extract to replace zinc oxide in suckling piglet feed, and it is also limited to partial replacement rather than full replacement, which cannot completely solve the problem of zinc oxide replacement. Summary of the invention

[0004] In order to solve the technical problems such as some deficiencies of zinc oxide as an additive in pig feed in the prior art, the present invention provides a terminalia chebula extract and a preparation method thereof and its application in weaned pig feed that completely replaces zinc oxide. The present invention can also solve the technical problems that the traditional terminalia chebula extract is only produced by simple crushing or decoction, and the simple crushing easily leads to low absorption rate of piglets, and the simple decoction easily leads to incomplete extraction of effective components, which is not conducive to subsequent application, and provides the preparation method of the terminalia chebula extract.

[0005] In the prior art, zinc oxide has good effects in preventing diarrhea and improving growth performance. The main reasons include:

[0006] Astringent effect: Astringent intestinal tract, up-regulate the expression of tight junction proteins, accelerate wound healing of intestinal mucosa, and promote the improvement of intestinal structure. Bactericidal effect: It can effectively inhibit and kill intestinal pathogens. Improve intestinal villus structure: Improve digestion and absorption of nutrients, and increase daily weight gain. Improve the body's antioxidant and anti-stress capabilities: Reduce intestinal irritation response. However, its disadvantages are also obvious, including: Pollution to the environment: Adding high zinc to feed will cause a large amount of fecal zinc to be excreted from the body, seriously polluting the environment. According to research reports, the zinc content in the soil around many pig farms has exceeded the planting standards for vegetables or grains. Harm to the health of suckling piglets: It can antagonize the absorption of other trace elements such as copper, iron, and manganese; consume gastric acid, reduce the digestion and absorption of nutrients, especially protein; long-term use reduces animal feed intake and causes pigs to have rough and messy back hair; leads to the development of drug resistance.

[0007] The present invention selects the terminalia chebula extract according to the mechanism of action and drawbacks reported in the above literature, combined with the actual effect and clinical experience of the terminalia chebula extract. Terminalia chebula belongs to tannins, and the mechanism of action of tannins is similar to that of zinc oxide, including: astringent effect; anti-pathogenic microorganisms (bacteria, viruses, protozoa, etc.); reducing endotoxin damage and inflammatory response; anti-oxidation effect; improving gastrointestinal barrier function; other effects: immunomodulatory effect; protecting the liver and kidneys, etc.

[0008] Among the tannin plant raw materials, terminalia chebula is widely used in traditional Chinese medicine and is widely used in the treatment of intestinal diseases and other diseases. Terminalia chebula is the dried mature fruit of the plant terminalia chebula or terminalia chebula of the Combretaceae family. It is produced in Guangxi, Yunnan, Xinjiang and other provinces and regions, India and Southeast Asia. It has the effects of astringing the intestines and stopping diarrhea, astringing the lungs and stopping coughs, and reducing fire and relieving sore throats. Since ancient times, terminalia chebula has occupied an important position in the field of traditional Chinese medicine and has been widely used in the treatment of various diseases. Ancient medical books such as "Compendium of Materia Medica" and "Shennong's Herbal Classic" have records of terminalia chebula. Terminalia chebula is used frequently in traditional Chinese medicine, Tibetan medicine and Mongolian medicine. For example, in traditional Chinese medicine, there are more than 220 ancient Chinese medicine prescriptions containing terminalia chebula, and in Tibetan medicine and Mongolian medicine, the proportion of terminalia chebula used exceeds 40%, so it is called "the king of Tibetan medicine" and "the king of Mongolian medicine".

[0009] The main components of Terminalia chebula include: hydrolyzed tannins, mainly terminalia acid, terminalia acid, terminalia acid, terminalia acid, terminalia chebula, etc., which have physiological effects such as astringency and antidiarrhea, antibacterial, anti-inflammatory, and antioxidant; triterpenoids, mainly terminalia chebula glycoside I, terminalia chebula glycoside II, 2α-hydroxymarcomerolic acid, etc., which have anti-inflammatory, antibacterial, antiviral, anticancer, immune enhancement and lipid-lowering effects; berberine, which mainly has anti-inflammatory, anti-tumor, hypoglycemic and lipid-regulating effects, and cardiovascular protection. Terminalia chebula also includes phenolic acids, polysaccharides and flavonoids, which play a role in enhancing immunity, anti-oxidation, and anti-inflammation. According to global research, the pharmacological effects of Terminalia chebula mainly include astringency, antioxidant, antibacterial, antifungal, antiviral, antiprotozoal, anticancer, radiation protection, chemoprevention, liver protection, and immune regulation. At the same time, Terminalia chebula is one of the 118 "other edible natural plants" listed in 7.6 of the "Catalogue of Feed Raw Materials" of the Ministry of Agriculture and Rural Affairs. It is allowed to be added to feed for a long time. It is a green, healthy and efficient plant extract additive product.

[0010] As a plant extract that can completely replace zinc oxide, the present invention compares the effects of Terminalia chebula extract and zinc oxide. From product design to production process to in vitro verification to animal experiment verification, we found that Terminalia chebula extract is superior to zinc oxide in terms of effectiveness and environmental friendliness, and is suitable for long-term addition in feed. It can completely replace zinc oxide, which not only provides a new choice for the health of the intestines of weaned pigs, but also contributes to reducing environmental pollution.

[0011] In order to realize the technical solution of the present invention, the following solutions are adopted:

[0012] The first object of the present invention is to provide a terminalia chebula extract which can completely replace zinc oxide in weaned pig feed. The active ingredients in the terminalia chebula extract are tannic acid>40%, flavonoids>2.5%, and polysaccharides>12% by mass.

[0013] In some embodiments of the present invention, the tannic acid in the Terminalia chebula extract is ≥50%, the flavonoids is ≥3.6%, and the polysaccharides is >14%.

[0014] The second object of the present invention is to provide a method for preparing a Terminalia chebula extract, comprising the following steps:

[0015] Provided is a terminalia chebula pulp, which is crushed to obtain terminalia chebula pulp powder, and then the terminalia chebula pulp powder is soaked in warm water to obtain a mixed liquid;

[0016] The obtained mixed solution is placed in an extraction tank and extracted with water as solvent to obtain an extract and medicinal residues;

[0017] The obtained extract is subjected to solid-liquid separation to obtain a liquid phase, and the liquid phase is concentrated under negative pressure to obtain a concentrate;

[0018] The obtained concentrate is dried to obtain the Terminalia chebula extract.

[0019] In some embodiments of the present invention, the mesh size of the crushed particles is 10-40 meshes, the warm water temperature is 30-70°C, the material-water ratio is 1:(5-8), and the soaking time is 2-4h.

[0020] In some embodiments of the present invention, the Terminalia chebula pulp is produced in Guangxi, Xinjiang or Yunnan, has normal sensory organs, a tannin content of >30%, no black core, and is powdery.

[0021] In some embodiments of the present invention, the extraction time is 2-3h, the extraction temperature is 50-85°C, the number of extractions is 2-3 times, and the liquid-to-solid ratio is (10-12): 1. After multiple comparative studies, the optimal process parameters are determined, under which the highest effective ingredient is obtained.

[0022] In some embodiments of the present invention, the negative pressure concentration is performed using a triple-effect concentrator, which is more conducive to the preservation of active ingredients;

[0023] In some embodiments of the present invention, the parameters of the triple-effect concentrator are: the evaporation temperature of the first-effect concentrator is 80-90°C, and the vacuum degree is -0.04 to -0.06 MPa; the evaporation temperature of the second-effect concentrator is 70-80°C, and the vacuum degree is -0.06 to -0.08 MPa; the evaporation temperature of the triple-effect concentrator is 50-70°C, and the vacuum degree is -0.08 to -0.10 MPa.

[0024] In some embodiments of the present invention, the drying is spray drying or diatomaceous earth adsorption vacuum negative pressure drying to prepare water-soluble powder and granules respectively. The water-soluble powder has good water solubility and high absorption efficiency; the granules have good flowability and a bulk density close to corn flour and soybean meal, and can be evenly added to the feed.

[0025] Furthermore, the vacuum negative pressure drying by diatomaceous earth adsorption is to use diatomaceous earth for adsorption and pulse airflow drying for drying. This drying method utilizes the rapid movement of hot air to remove almost all moisture, and the dried material will not deteriorate; wherein the mesh number of the diatomaceous earth is 50-100 mesh, and the dosage is 400-500g / kg of the concentrated material.

[0026] In some embodiments of the present invention, the spray drying conditions are as follows: an inlet air temperature of 145-175° C., an outlet air temperature of 70-100° C., and a material pump speed of 10-25 rpm.

[0027] The third object of the present invention is to provide an antibacterial agent, which comprises the Terminalia chebula extract or the Terminalia chebula extract obtained by the preparation method.

[0028] The fourth object of the present invention is to provide a weaned piglet feed regulator, comprising the terminalia chebula extract or the terminalia chebula extract obtained by the preparation method or the above-mentioned antibacterial agent, wherein the terminalia chebula extract completely replaces zinc oxide in weaned piglet feed.

[0029] In some embodiments of the present invention, the added amount of the weaned piglet feed regulator is 500-1500 grams per ton.

[0030] The above technical solution of the present invention has the following advantages compared with the prior art:

[0031] (1) The Terminalia chebula extract prepared by the present invention is subjected to multiple experimental comparative studies to select the best process parameters to achieve the best product yield, reduce the loss of effective ingredients, and obtain the highest effective ingredient conversion rate. The final effective ingredient content is total tannin>40%, flavonoids>2.5%, and polysaccharides>12%.

[0032] (2) The Terminalia chebula extract prepared by the present invention has a strong antibacterial effect on Escherichia coli and Staphylococcus aureus through MIC and MBC experiments, and the effect is much better than zinc oxide. At the same time, it protects intestinal health and prevents diarrhea in piglets.

[0033] (3) The Terminalia chebula extract prepared by the present invention, through in vitro animal experiments, with an addition amount of 500-1500 g per ton, showed that it can improve the growth performance, antioxidant activity and intestinal mucosal barrier function of weaned piglets, and the effect is equivalent to that of zinc oxide.

[0034] (4) Through the above research, the Terminalia chebula extract prepared by the present invention can completely replace the use of zinc oxide in weaned pig feed, can be suitable for antibiotic-free breeding, and has the characteristics of safety, no side effects, and rapid effect.

[0035] (5) The product molding process was studied to produce two dosage forms suitable for use in practical applications. One is a water-soluble dosage form, which is suitable for mixing with feed or drinking water and has a high absorption rate. The other is a granular dosage form, which has good flowability, is not easy to clump, and can be evenly added to the feed. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] In order to make the content of the present invention more clearly understood, the present invention is further described in detail below according to specific embodiments of the present invention in conjunction with the accompanying drawings, wherein:

[0037] Figure 1 This is the extraction technology route of the present invention.

[0038] Figure 2 This is the drying technology route of the present invention.

[0039] Figure 3This is a diagram of the in vitro antibacterial effect of the terminalia chebula extract powder and zinc oxide obtained in the embodiment pointed out in Test Example 2 of the present invention on Escherichia coli, wherein, from left to right, the first group is the blank control group, the second to fifth groups are the terminalia chebula extract-containing groups, and the sixth to ninth groups are the zinc oxide-containing groups.

[0040] Figure 4 This is a diagram showing the in vitro antibacterial effect of the terminalia chebula extract powder and zinc oxide obtained in the embodiment indicated in Test Example 4 of the present invention on Staphylococcus aureus, wherein, from left to right, the first group is a blank control group, the second to fifth groups are groups containing terminalia chebula extract, and the sixth to ninth groups are groups containing zinc oxide.

[0041] Figure 5 This is a picture showing the effects of the Terminalia chebula extract powder obtained in the embodiment indicated in Test Example 5 of the present invention and zinc oxide on the cecal flora structure of suckling piglets.

[0042] Figure 6 It is a picture showing the effects of the Terminalia chebula extract powder obtained in the embodiment pointed out in Test Example 5 of the present invention and zinc oxide on the intestinal morphology of suckling piglets. DETAILED DESCRIPTION

[0043] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.

[0044] Example 1

[0045] Weigh 50 parts of chebula pulp that have passed the test (yellow-brown or dark brown in appearance, without black core, firm in texture, thick and abundant in pulp) by weight, crush through a 10-mesh sieve, then add 5 times of water and heat to 30°C, soak for 2 hours, and obtain a chebula pulp powder mixed solution. Put the mixed solution into an extraction tank, add 250 parts of water, set the extraction temperature to 50°C, and the extraction time to 2 hours, wherein the extraction is performed twice, each time for 1 hour, heat and concentrate the obtained extract to a relative density of 1.08, filter with a filter, and then use a triple-effect concentrator to concentrate the obtained filtrate, the triple-effect vacuum degree and evaporation temperature are: the first-effect evaporation temperature is 80°C, the vacuum degree is -0.04~-0.06MPa, the second-effect evaporation temperature is 70°C, the vacuum degree is -0.06~-0.08MPa, and the triple-effect evaporation temperature is 50°C, the vacuum degree is -0.08~-0.10MPa. After concentration, spray drying was performed, and the process conditions were as follows: the inlet air temperature was 145°C, the outlet air temperature was 70°C, and the feed pump speed was 10rpm. Finally, 25 portions of Terminalia chebula extract were obtained, and the total tannic acid, flavonoids, and polysaccharides were 52.0%, 3.8%, and 14.0%, respectively.

[0046] Example 2

[0047] Weigh 100 parts of the chebula pulp that has passed the test (same as above) by weight, crush it through a 20-mesh sieve, add 6 times of water and heat it to 50°C, soak it for 3 hours, and obtain a chebula pulp powder mixed solution. Put the mixed solution into an extraction tank, add 600 parts of water, set the extraction temperature to 60°C, and the extraction time to 2.5 hours, wherein the extraction is performed twice, the first time for 1.5 hours, and the second time for 1 hour; heat the obtained extract and concentrate it to a relative density of 1.09, filter it with a filter, and then use a triple-effect concentrator to concentrate the obtained filtrate, the triple-effect vacuum degree and evaporation temperature are: the first-effect evaporation temperature is 85°C, the vacuum degree is -0.04 to -0.06MPa, the second-effect evaporation temperature is 75°C, the vacuum degree is -0.06 to -0.08MPa, and the triple-effect evaporation temperature is 60°C, and the vacuum degree is -0.08 to -0.10MPa. After concentration, spray drying was performed, and the process conditions were as follows: the inlet air temperature was 160°C, the outlet air temperature was 90°C, and the feed pump speed was 20rpm. Finally, 55 portions of Terminalia chebula extract were obtained, and the total tannic acid, flavonoids, and polysaccharides were 53.1%, 4.1%, and 15.0%, respectively.

[0048] Example 3

[0049] Weigh 200 parts of qualified chebula pulp by weight, crush through a 40-mesh sieve, add 8 times of water and heat to 70°C, soak for 4 hours to obtain a chebula pulp powder mixture. Put the chebula pulp into an extraction tank, add 800 parts of water, set the extraction temperature to 100°C, and the extraction time to 3 hours, wherein the extraction is performed 3 times, each time for 1 hour, heat and concentrate the obtained extract to a relative density of 1.10, filter with a filter, and then use a triple-effect concentrator to concentrate the obtained filtrate, the triple-effect vacuum degree and evaporation temperature are: the first-effect evaporation temperature is 90°C, the vacuum degree is -0.04 to -0.06MPa, the second-effect evaporation temperature is 80°C, the vacuum degree is -0.06 to -0.08MPa, and the triple-effect evaporation temperature is 70°C, and the vacuum degree is -0.08 to -0.10MPa. After concentration, spray drying was performed, and the process conditions were as follows: inlet air temperature was 175°C, outlet air temperature was 100°C, and feed pump speed was 25 rpm. Finally, 100 portions of Terminalia chebula extract were obtained, and the total tannic acid, flavonoids, and polysaccharides were 50%, 3.6%, and 14.5%, respectively.

[0050] Comparative Example 1

[0051] Weigh 50 parts of qualified Terminalia chebula pulp by weight, crush through a 10-mesh sieve, add 5 times of water, soak in cold water (10-20°C) for 2 hours to obtain a Terminalia chebula pulp powder mixture. Put the Terminalia chebula pulp into an extraction tank, add 250 parts of water, set the extraction temperature to 50°C, extract for 2 hours, extract twice, each time for 1 hour, and heat and concentrate to a relative density of 1.08. Filter with a filter, and then use a triple-effect concentrator to concentrate. The triple-effect vacuum degree and evaporation temperature are: the first-effect evaporation temperature is 80°C, the vacuum degree is -0.04~-0.06MPa, the second-effect evaporation temperature is 70°C, the vacuum degree is -0.06~-0.08MPa, and the triple-effect evaporation temperature is 50°C, and the vacuum degree is -0.08~-0.10MPa. After concentration, spray drying was performed, and the process conditions were as follows: inlet air temperature was 145°C, outlet air temperature was 70°C, and the feed pump speed was 10 rpm. Finally, 20 portions of Terminalia chebula extract were obtained, and the total tannic acid, flavonoids, and polysaccharides were 48.0%, 3.5%, and 13.5%, respectively.

[0052] The products obtained in Example 1 and Comparative Example 1 are compared, and the results are shown in Table 1. It can be seen from Table 1 that the yield of the Terminalia chebula extract obtained by soaking in warm water is higher and the content of the active ingredient is also slightly higher. The results are as follows (Table 1).

[0053] Table 1 Differences in effective ingredients of products soaked in different water temperatures

[0054]

[0055] Test Example 1 Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the product of the present invention and zinc oxide on Escherichia coli

[0056] The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the powder obtained by this product (Example 1) and zinc oxide against Escherichia coli were determined by double dilution method. The specific method is as follows: take 11 sterile test tubes, number them in sequence, take 2.0mL of each drug solution and add it to test tube No. 1, mix it by pipetting, take 2.0mL of solution and add it to test tube No. 2, dilute it to test tube No. 9 in sequence, after test tube No. 9 is mixed, take 2.0mL and discard it, test tube No. 10 is used as a negative control without adding drug solution to verify whether the culture medium is suitable for bacterial growth, test tube No. 11 is added with 2.0mL of drug solution, after mixing, take out 2.0mL and discard it, and do not inoculate bacterial solution to verify whether the drug is contaminated by bacteria. After the dilution is completed, 0.1mL of bacterial solution is inoculated into test tubes No. 1-10 respectively, and each drug is repeated twice. After mixing, it is placed in an incubator for culture (37°C, 22-24h), and the results are observed. The lowest concentration in the clear transparent tube is taken as MIC. On the basis of the MIC determination of a single extract, the culture solution of the clear test tube and the nearby test tube was evenly spread on the sterile nutrient agar plate using a sterile spreader rod, placed in a 37°C biochemical incubator, cultured for 24 hours, and then taken out for observation. Three parallels were measured for each group. The minimum concentration at which no bacteria grew on the plate or the inhibition rate was above 99% was taken as the MBC. The MIC and MBC results are as follows (Table 2).

[0057] Table 2 MIC and MBC results of Terminalia chebula extract and zinc oxide against Escherichia coli

[0058] product MIC (mg / mL) MBC (mg / mL) Terminalia chebula extract 0.15625 0.3125 Zinc Oxide 5 10

[0059] The MIC of Terminalia chebula extract and zinc oxide against Escherichia coli were 0.15625 mg / mL and 5 mg / mL, and the MBC were 0.3125 mg / mL and 10 mg / mL, respectively, indicating that both Terminalia chebula extract and zinc oxide have antibacterial effects, and the antibacterial effect of Terminalia chebula extract is significantly better than that of zinc oxide.

[0060] Test Example 2 In vitro antibacterial test of the product of the present invention and zinc oxide on Escherichia coli

[0061] The plate count method was used to determine the in vitro antibacterial effect of the powder obtained by this product (Example 1) and zinc oxide on Escherichia coli. The specific method is as follows: accurately weigh the zinc oxide group and the terminalia chebula extract group (the added amounts are 250g / T, 500g / T, 1000g / T, and 2000g / T, respectively), a total of 8 groups, and set up a blank control group at the same time, transfer the 9 groups of samples into bottles with corresponding numbers, and finally add 3mL of the test bacterial solution to each of the 9 groups of bottles, and put them into an shaking incubator at 37°C for 4h. Take them out, prepare the solid culture medium in advance and lay out the culture dishes, make 2 parallels for each group, take 0.1mL of the test solution for coating, put them into the incubator for culture for 18-24h, take them out for observation, and the results are as follows (Table 3, Table 4, Figure 3 ).

[0062] Table 3 Colony count

[0063]

[0064]

[0065] Table 4 Antibacterial rate

[0066]

[0067] Figure 3 Culture results

[0068] The test results show that both Terminalia chebula extract and zinc oxide have antibacterial effects, and Terminalia chebula extract is significantly better than zinc oxide. Adding 250 grams per ton in feed can achieve a good antibacterial effect.

[0069] Test Example 3 Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the product of the present invention and zinc oxide against Staphylococcus aureus.

[0070] The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the powder obtained by this product (Example 2) and zinc oxide against Escherichia coli were determined by double dilution method. The specific method is as follows: take 11 sterile test tubes, number them in sequence, take 2.0mL of each drug solution and add it to test tube No. 1, mix it by pipetting, take 2.0mL of solution and add it to test tube No. 2, dilute it to test tube No. 9 in sequence, after test tube No. 9 is mixed, take 2.0mL and discard it, test tube No. 10 is used as a negative control without adding drug solution to verify whether the culture medium is suitable for bacterial growth, test tube No. 11 is added with 2.0mL of drug solution, after mixing, take out 2.0mL and discard it, and do not inoculate bacterial solution to verify whether the drug is contaminated by bacteria. After the dilution is completed, 0.1mL of bacterial solution is inoculated into test tubes No. 1-10 respectively, and each drug is repeated twice. After mixing, it is placed in an incubator for culture (37°C, 22-24h), and the results are observed. The lowest concentration in the clear transparent tube is taken as MIC. On the basis of the MIC determination of a single extract, the culture solution of the clear test tube and the nearby test tube was evenly spread on the sterile nutrient agar plate using a sterile spreader stick, placed in a 37°C biochemical incubator, cultured for 24 hours, and then taken out for observation. Three parallels were measured for each group. The minimum concentration at which no bacteria grew on the plate or the inhibition rate was above 99% was taken as the MBC. The MIC and MBC results are as follows (Table 5).

[0071] Table 5 MIC and MBC results of Terminalia chebula extract and zinc oxide against Staphylococcus aureus

[0072] product MIC (mg / mL) MBC (mg / mL) Terminalia chebula extract 0.0125 0.025 Zinc Oxide 0.625 1.25

[0073] The MICs of Terminalia chebula extract and zinc oxide against Staphylococcus aureus were 0.0125 mg / mL and 0.625 mg / mL, and the MBCs were 0.025 mg / mL and 1.25 mg / mL, respectively, indicating that both Terminalia chebula extract and zinc oxide have antibacterial effects, and the antibacterial effect of Terminalia chebula extract is significantly better than that of zinc oxide.

[0074] Test Example 4 In vitro antibacterial test of the product of the present invention and zinc oxide on Staphylococcus aureus

[0075] The plate count method was used to determine the in vitro antibacterial effect of the powder obtained from this product (Example 2) and zinc oxide on Staphylococcus aureus. The specific method is as follows: accurately weigh the zinc oxide group and the terminalia chebula extract group (the added amounts are 250g / T, 500g / T, 1000g / T, and 2000g / T, respectively), a total of 8 groups, and set up a blank control group at the same time, transfer the 9 groups of samples into bottles with corresponding numbers, and finally add 3mL of the test bacterial solution to each of the 9 groups of bottles, and put them into an shaking incubator at 37°C for 4h. Take them out, prepare the solid culture medium in advance and lay out the culture dishes, make 2 parallels for each group, take 0.1mL of the test solution for coating, put them into the incubator for culture for 18-24h, take them out for observation, and the results are as follows (Table 6, Table 7, Figure 4 ).

[0076] Table 6 Colony count

[0077]

[0078]

[0079] Table 7 Antibacterial rate

[0080]

[0081] Figure 4 Culture results

[0082] The test results show that both the terminalia chebula extract and zinc oxide have antibacterial effects on Staphylococcus aureus, and the terminalia chebula extract is significantly better than zinc oxide. The addition of 250 grams per ton in the feed can achieve a good antibacterial effect. Moreover, the terminalia chebula extract group has smaller colonies of Staphylococcus aureus and lighter color. This shows that for bacteria that are not killed, terminalia chebula extract also has the effect of weakening the vitality of the strain.

[0083] Test Example 5 Comparison of the effects of the product of the present invention and zinc oxide on diarrhea and production performance of suckling piglets. This experiment was completed in cooperation with the Institute of Subtropical Agricultural Sciences, University of Chinese Academy of Sciences.

[0084] Animal experiments were used to determine the effects of the powder obtained from this product (Example 3) and zinc oxide on diarrhea and production performance in suckling piglets. 120 28-day-old weaned piglets (Duroc×Landrace×Large White) with the same genetic background, the same batch, and normal development, with an average weight of 7.43 kg, were selected. The piglets were castrated and randomly divided into 5 treatments (Table 8) according to the principle of half male and half female and homogenization of maternal sources, with 6 replicates in each treatment and 4 pigs in each replicate. After 2 days of pre-feeding, a 4-week formal test was carried out.

[0085] Table 8 Grouping Processing

[0086] project deal with Processing 1 Basic feed Processing 2 Basic diet + 2g / kg zinc oxide Processing three Basic diet + 1g / kg Terminalia chebula extract Processing Four Basic diet + 2g / kg Terminalia chebula extract Processing Five Basic diet + 4g / kg Terminalia chebula extract

[0087] The experimental diet is a corn-soybean meal type diet, which is formulated with reference to the nutritional requirements of weaned piglets in NRC (2012) (Table 9). Before the experiment, the feed trough and waterer were cleaned, the pig house was thoroughly disinfected, and the experimental pigs were routinely immunized and dewormed. Feed 4 times a day (8 am, 10 am, 2 pm, and 5 pm), feed less and add more frequently, and the feeding amount is based on a slight surplus in the feed trough. The feeding and management conditions of each group are consistent. The temperature of the pig house is controlled at around 25°C, and the pens are kept ventilated, clean, dry, and hygienic. Disinfection is carried out according to the routine management procedures of the farm. Strictly follow the pig farm feeding and management system, pay attention to their behavior, feeding, drinking and diarrhea every day, and record and deal with any abnormalities in a timely manner.

[0088] Table 9 Composition and nutritional level of basic diet

[0089]

[0090]

[0091] The premix provide the following per kg of the diet: VA, 12000IU; VD, 2500IU; VE, 30IU; VB12, 12μg; VK, 3mg; pantothenic acid, 15mg; niacin, 40mg; choline chloride, 400mg; Mn (MnSO4.H2O), 40mg; Zn (ZnSO4.H2O), 100mg; Fe (FeSO4.H2O), 90mg; Cu (CuSO4.5H2O), 8.8mg; I (KI), 0.35mg; Se (Na2SeO3), 0.3mg.

[0092] Measurement indicators

[0093] Growth performance indicators

[0094] Each pig was weighed before morning feeding on the 0th, 14th, and 28th day of the experiment. During the experiment, the defecation of the piglets was observed from 9:00 to 10:00 and 16:00 to 17:00 every day, and the diarrhea individuals were recorded. The elimination and death of pigs were recorded in a timely manner on an individual basis, and the feed was collected and weighed in time when dead pigs occurred. The average daily feed intake was calculated based on the daily recorded feeding amount, residual feed amount, and feed consumption. During the experiment, the average daily weight gain (ADG), average daily feed intake (ADFI), feed-to-weight ratio (F / G), and diarrhea rate were recorded in units of repetitions. The results are as follows (Table 10).

[0095] Average daily feed intake (ADFI) = total feed intake / (number of experimental days × number of experimental pigs);

[0096] Average daily gain (ADG) = (average weight at the end of the experiment - average initial weight at the beginning of the experiment) / (number of experimental days × number of experimental pigs);

[0097] Material-to-weight ratio (F / G) = total material consumption / total weight gain

[0098] Mortality rate (%) = number of dead piglets / number of test piglets × 100%.

[0099] During the experiment, the diarrhea of ​​piglets in each group was observed and recorded regularly every day (if the feces were sticky and had a water content of ≥70%, it was considered diarrhea), and the diarrhea rate was calculated according to the following formula.

[0100] Diarrhea rate (%) = (total number of piglets with diarrhea during the entire test period × number of times) / (number of feeding days × total number of piglets) × 100%;

[0101] Table 10 Production performance and diarrhea index

[0102]

[0103]

[0104] Experimental results: Compared with the control group, the 1g / kg, 2g / kg, and 4g / kg terminalia chebula groups can improve the production performance of weaned piglets and significantly reduce diarrhea; compared with the zinc oxide group, the 1g / kg, 2g / kg, and 4g / kg terminalia chebula groups have better production performance, and the diarrhea rate is slightly higher but acceptable in production. The results show that terminalia chebula extract can improve animal production performance, reduce diarrhea, and can completely replace zinc oxide to a certain extent.

[0105] Antioxidant effect of serum

[0106] On the 28th day of the experiment, one weaned piglet with a weight close to the average was selected from each replicate after weighing on an empty stomach. 10 mL of blood was collected from the anterior vena cava. After standing for 30 minutes, the blood was centrifuged at 3500 r / min for 10 minutes to prepare serum. The serum was packaged and stored at -20°C for testing. The total antioxidant capacity (T-AOC), catalase (CAT), glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activities and malondialdehyde (MDA) content in the serum were determined according to the kit instructions. The results are as follows (Table 11).

[0107] Table 11 Serum antioxidant index

[0108]

[0109]

[0110] Notes: T-AOC total antioxidant capacity; SOD superoxide dismutase; CAT catalase; GSH-Px glutathione peroxidase; MDA malondialdehyde.

[0111] Experimental results: Compared with the control group, the addition of 1g / kg, 2g / kg and 4g / kg of Terminalia chebula extract increased the total antioxidant capacity (T-AOC), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) of serum, and reduced the concentration of malondialdehyde (MDA); compared with the zinc oxide group, the total antioxidant capacity of 4g / kg Terminalia chebula extract was higher, while the 2g / kg group was equivalent to the zinc oxide group. This shows that different addition amounts of Terminalia chebula extract can improve serum antioxidant capacity, suggesting that this is helpful for resisting oxidative stress and improving meat quality.

[0112] Antioxidant effect on liver

[0113] Before the antioxidant function test of liver tissue samples, they need to be homogenized. The specific method is as follows: take 0.2 g of frozen liver tissue sample, add 0.9% saline into a homogenization cup to make a 10% homogenate, centrifuge the homogenate at 4°C and 4000 r / min for 20 min, separate the supernatant for testing, and use the same method as above. The results are as follows (Table 12).

[0114] Table 12 Liver antioxidant index

[0115]

[0116]

[0117] Notes: T-AOC total antioxidant capacity; SOD superoxide dismutase; CAT catalase; GSH-Px glutathione peroxidase; MDA malondialdehyde.

[0118] Experimental results: Compared with the control group, the addition of 1g / kg, 2g / kg and 4g / kg of Terminalia chebula extract increased the total antioxidant capacity (T-AOC) and superoxide dismutase (SOD) of the liver, and reduced the concentration of malondialdehyde (MDA); compared with the zinc oxide group, the group with 4g / kg Terminalia chebula extract had a higher total antioxidant capacity (T-AOC) and lower malondialdehyde (MDA), and was basically equivalent to the zinc oxide group in superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px), while the 1g / kg and 2g / kg groups were inferior to the zinc oxide group. In general, the addition of different doses of Terminalia chebula extract can improve the antioxidant capacity of the liver, enhance the resistance to oxidative stress and the metabolic function of the liver.

[0119] Antioxidant effects of the spleen

[0120] Before the antioxidant function test of spleen tissue samples, they need to be homogenized. The specific method is as follows: take 0.2 g of frozen spleen tissue sample, add 0.9% saline into a homogenization cup to make a 10% homogenate, centrifuge the homogenate at 4°C and 4000 r / min for 20 min, separate the supernatant for testing, and use the same method as above. The results are as follows (Table 13).

[0121] Table 13 Antioxidant indexes of spleen

[0122]

[0123]

[0124] Notes: T-AOC total antioxidant capacity; SOD superoxide dismutase; CAT catalase; GSH-Px glutathione peroxidase; MDA malondialdehyde.

[0125] Experimental results: Compared with the control group, the addition of 1g / kg, 2g / kg and 4g / kg of Terminalia chebula extract increased the total antioxidant capacity (T-AOC), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) of the jejunum, and reduced the concentration of malondialdehyde (MDA); compared with the zinc oxide group, the total antioxidant capacity (T-AOC) of the Terminalia chebula extract added at 2g / kg was higher, and the superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) of the Terminalia chebula extract added at 4kg were higher, and the superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) of the other groups were basically equivalent to the zinc oxide group. This shows that different addition amounts of Terminalia chebula extract can improve the antioxidant capacity of the spleen, enhance the resistance to oxidative stress and the immune regulation function of the spleen.

[0126] Cecal microbial assay

[0127] High-throughput sequencing technology was used to sequence the 16S rRNA gene of colonic matter and analyze the structure of cecal flora. The results are as follows ( Figure 5 )

[0128] Note: Lactobacillaceae; Stresptococcaceae; Rumiococcaceas

[0129] Experimental results: Compared with the control group, the abundance of Lactobacillaceae in the chebula extract group and zinc oxide group was significantly higher, and the abundance of Ruminococcaceae in the chebula extract group was also significantly increased; and the abundance of Streptococcaceae in the chebula extract group and zinc oxide group was significantly reduced. This shows that both chebula extract and zinc oxide protect intestinal health by increasing beneficial bacteria such as intestinal lactobacilli and Ruminococcus and reducing streptococci.

[0130] Villus length and crypt depth measurement

[0131] On the 28th day of the experiment, one weaned piglet was selected from each replicate, and the weight was recorded before slaughtering. During the slaughter process, the abdominal cavity was opened, and the intestinal segments were quickly removed and separated. The tissue samples were made into wax blocks through the procedures of tissue washing-dehydration-transparent-wax dipping-embedding, and paraffin sections were made using a LEICARM2135 slicer. Tissue sections were made through the procedures of spreading, staining, and sealing. Images were then collected using a microscopic camera, and the villus length and crypt depth of the sections were measured using software, and the ratio of the villus length to the crypt depth of each treatment was calculated. The results are as follows (Table 14). The cecum was ligated, wrapped in tin foil, and stored in liquid nitrogen for the determination of cecal microorganisms. Approximately 3 cm long intestinal segments of the duodenum, jejunum, and middle ileum were taken and fixed with fixative for the preparation of intestinal tissue sections. The results are as follows ( Figure 5 ).

[0132] Table 14 Villus length and crypt depth index

[0133]

[0134] Experimental results: Compared with the control group, except for the jejunum of the group with 1g / kg added, each terminalia group can increase the height of the intestinal villi of weaned piglets, reduce the depth of the crypts, and increase the ratio of the height of the villi to the depth of the crypts; compared with the zinc oxide group, the height of the duodenal villi, the depth of the crypts, and the ratio of the height of the villi to the depth of the crypts of each terminalia group are better than those of the zinc oxide group, and the zinc oxide group is generally better in the jejunum and ileum related indicators. The results show that terminalia extract can significantly improve the health of intestinal villi, enhance the ability to absorb nutrients, and reduce the risk of diarrhea. Compared with zinc oxide, it has different focuses on the improvement of the duodenum, jejunum, and ileum.

[0135] The experimental results showed that the height of intestinal villi in the zinc oxide group and the terminalia chebula extract group was higher and the height of crypts was lower than that in the control group, indicating that the intestinal villi were more complete, indicating that terminalia chebula extract can completely replace zinc oxide in terms of the health level of intestinal villi.

[0136] Determination of intestinal volatile fatty acids

[0137] The cecum and colon were cut into pieces of about 5 cm in length, quickly frozen in liquid nitrogen, and stored at -80°C. The results are as follows (Table 15).

[0138] Table 15 Intestinal volatile fatty acid index

[0139]

[0140]

[0141] Experimental results: Compared with the control group, the addition of 1g / kg, 2g / kg and 4g / kg of Terminalia chebula extract increased the total volatile fatty acids in the cecum and colon, especially butyric acid, valeric acid, isobutyric acid, etc. Compared with the zinc oxide group, the addition of 2g / kg and 4g / kg Terminalia chebula extract increased the total volatile fatty acids in the cecum, while the total volatile fatty acids in the colon were slightly lower. This shows that Terminalia chebula extract can improve intestinal health by increasing intestinal volatile fatty acids to provide energy for the intestine.

[0142] Intestinal permeability assay

[0143] The ELISA kit was used to detect the levels of endotoxin, diamine oxidase (DAO) and D-lactic acid in serum. The results are as follows (Table 16).

[0144] Table 16 Intestinal permeability index

[0145]

[0146]

[0147] The test results showed that compared with the control group, the IgA, IgG, and IgM in the terminalia chebula extract group were all increased, and D-lactic acid was reduced, indicating that terminalia chebula extract has the effect of enhancing intestinal immunity and reducing intestinal mucosal damage. Compared with the zinc oxide group, the 4g / kg terminalia chebula extract group had the same effect as the zinc oxide group, and can replace the use of zinc oxide to a certain extent.

[0148] Intestinal mucosal index

[0149] Another 5 cm length of the middle of each intestinal segment was taken, cleaned and transversely cut open, and the intestinal epithelial mucosal tissue was collected with a glass plate in tin foil, quickly frozen in liquid nitrogen, and stored at -80°C. The jejunal and ileal mucosa were tested for immune indicators: secretory immunoglobulin A (sIg A), IL-4, IL-10, TNF-α, IL-1β, IFN-β, IL-6 content and antioxidant indicators: T-AOC, T-SOD, MDA, CAT, GSH-PX activity, and the results are as follows (Table 17, Table 18).

[0150] Table 17 Antioxidant indexes of jejunal mucosa

[0151]

[0152]

[0153] Notes: T-AOC total antioxidant capacity; SOD superoxide dismutase; CAT catalase; GSH-Px glutathione peroxidase; MDA malondialdehyde.

[0154] Experimental results: Compared with the control group, the addition of 1g / kg, 2g / kg and 4g / kg of Terminalia chebula extract increased the total antioxidant capacity (T-AOC), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) of the jejunum, and reduced the concentration of malondialdehyde (MDA); compared with the zinc oxide group, the addition of 1g / kg, 2g / kg and 4g / kg of Terminalia chebula extract had a higher total antioxidant capacity (T-AOC), and each group showed a level of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) that was basically equivalent to or higher than that of the zinc oxide group. This shows that different amounts of Terminalia chebula extract can improve the antioxidant capacity of the jejunal mucosa and enhance the intestinal resistance to pathogens or adverse challenges.

[0155] Table 18 Jejunal mucosal immune indexes

[0156]

[0157]

[0158] Experimental results: From the perspective of immunoglobulin, compared with the control group, the addition of 1g / kg, 2g / kg and 4g / kg of Terminalia chebula extract increased sIgA, IgG, and IgM in the jejunal mucosa; compared with zinc oxide, the 4g / kg Terminalia chebula group increased the IgG and IgM content. From the perspective of other immune indicators, compared with the control group, the addition of 1g / kg, 2g / kg and 4g / kg Terminalia chebula extract increased the content of anti-inflammatory factors IL-4 and IL-10, and the 1g / kg and 4g / kg groups were higher than the zinc oxide group. The pro-inflammatory factors IL-6 and IL-1β in the 2g / kg and 4g / kg groups were reduced. The addition of 1g / kg, 2g / kg and 4g / kg Terminalia chebula extract also reduced the content of tumor necrosis factor (TNFα), indicating that Terminalia chebula extract can protect intestinal health by enhancing jejunal mucosal immunity and reducing inflammatory response.

[0159] Test Example 6 Comparison of the effects of the product of the present invention and zinc oxide on diarrhea and production performance of suckling piglets. This experiment was conducted on a large group during the actual production process and was independently completed by Wuxi Zhengda Company.

[0160] Animal experiments were conducted to determine the effects of the powder obtained from this product (Example 3) and zinc oxide on diarrhea and production performance in suckling piglets, and to study the effects of adding terminalia chebula extract to the diet on the growth performance and intestinal health of weaned piglets when replacing all zinc oxide, providing a basis for the promotion and application of this product in weaned pig feed. Weaned piglets were selected at 21 days of age with an average weight of 6.3 kg.

[0161] Experimental design

[0162] The experiment selected 226 piglets born from 20 litters of the same batch of Duchangda sows, weaned at 21 days of age, with an average weight of 6.32 kg, and randomly divided into 3 treatments (Table 19) according to the principle of half male and half female, with 4 replicates in each treatment and 17-18 pigs in each replicate. The experimental period was 21 days (November 3-November 23, 2021)

[0163] Table 19 Grouping

[0164] project deal with Processing 1 Basic feed Process 2 Basic diet + 2g / kg zinc oxide Processing three Basic diet + 1g / kg Terminalia chebula extract

[0165] Note: The basic feed is the creep feed Baby Zhuang produced by Wuxi Zhengda Biotechnology Co., Ltd. The main nutritional indicators are (crude protein>18%, digestible energy>3440MCal / kg, lysine>1.36%, methionine+threonine>0.75%, calcium>0.78%, phosphorus>0.65%)

[0166] Feeding and management

[0167] Before the test, clean the trough and waterer, thoroughly disinfect the pig house, and perform routine immunization and deworming on the experimental pigs. Feed 4 times a day (8 am, 10 am, 2 pm, 5 pm), feed less and add more frequently, and the feeding amount is based on a slight surplus in the trough. The feeding and management conditions of each group are consistent. The temperature of the pig house is controlled at around 25°C, and the house is kept ventilated, clean, dry and hygienic. Disinfection is carried out according to the routine management procedures of the farm. Strictly follow the pig farm feeding and management system, pay attention to their behavior, feeding, drinking and diarrhea every day, and record and deal with any abnormalities in a timely manner.

[0168] Measurement indicators

[0169] The pigs were weighed on an empty stomach on the day of weaning and the morning of the end of the experiment. Each pen was weighed together. During the experiment, the defecation of the piglets was observed from 9:00 to 10:00 and 16:00 to 17:00 every day, and the diarrhea individuals were recorded. The elimination and death of pigs were recorded in a timely manner on an individual basis. When dead pigs were eliminated, the feed was collected and weighed in time. The average daily feed intake was calculated based on the daily recorded feeding amount, residual feed amount and feed consumption. During the experiment, the average daily weight gain (ADG), average daily feed intake (ADFI), feed-to-weight ratio (F / G) and diarrhea rate (calculation method is the same as above) were recorded in units of repetitions. The results are as follows (Table 20).

[0170] Table 20 Effect of Terminalia chebula extract replacing zinc oxide on production performance and intestinal health of weaned piglets

[0171]

[0172] Experimental results: Compared with the control, adding 1kg of terminalia chebula extract and zinc oxide per ton of feed significantly increased the daily weight gain of weaned piglets, reduced feed-to-meat ratio, diarrhea rate and mortality, and there was no significant difference between 2kg zinc oxide and 1kg terminalia chebula extract in various indicators. This shows that in large-scale production practice, it is feasible to replace 2kg zinc oxide with 1kg terminalia chebula extract per ton of feed.

[0173] The present invention provides a terminalia chebula extract that completely replaces zinc oxide in weaned pig feed, and a preparation method and application thereof. There are many methods and approaches to implement the technical solution. The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be regarded as the protection scope of the present invention. All components not specified in this embodiment can be implemented by existing technologies.

[0174] Obviously, the above embodiments are merely examples for clear explanation and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived from these are still within the protection scope of the invention.

Claims

1. A Terminalia chebula extract, characterized in that Calculated by mass percentage, the active ingredients in the terminalia chebula extract include tannic acid>40%, flavonoids>2.5%, and polysaccharides>12%.

2. The Terminalia chebula extract according to claim 1, characterized in that The terminalia chebula extract contains tannic acid ≥50%, flavonoids ≥3.6% and polysaccharides >14%.

3. The method for preparing the Terminalia chebula extract according to claim 1 or 2, characterized in that: The following steps are involved: Provided is a terminalia chebula pulp, which is crushed to obtain terminalia chebula pulp powder, and then the terminalia chebula pulp powder is soaked in warm water to obtain a mixed liquid; The obtained mixed solution is placed in an extraction tank and extracted with water as solvent to obtain an extract and medicinal residues; The obtained extract is subjected to solid-liquid separation to obtain a liquid phase, and the liquid phase is concentrated under negative pressure to obtain a concentrate; The obtained concentrate is dried to obtain the Terminalia chebula extract.

4. The preparation method according to claim 3, characterized in that: The mesh size of the crushing is 10-40 meshes, the warm water temperature is 30-70°C, the material-water ratio is 1:(5-8), and the soaking time is 2-4h.

5. The preparation method according to claim 3, characterized in that: The chebula pulp has normal sensory properties, a tannin content of more than 30%, no black core, and is powdery.

6. The preparation method according to claim 3, characterized in that: The extraction time is 2-3 hours, the extraction temperature is 50-85° C., the number of extractions is 2-3 times, and the liquid-to-solid ratio is (10-12):

1.

7. The preparation method according to claim 3, characterized in that: The negative pressure concentration adopts a triple-effect concentrator for negative pressure concentration. The parameters of the triple-effect concentrator are as follows: the evaporation temperature of the first-effect concentrator is 80-90°C, and the vacuum degree is -0.04 to -0.06MPa; the evaporation temperature of the second-effect concentrator is 70-80°C, and the vacuum degree is -0.06 to -0.08MPa; the evaporation temperature of the triple-effect concentrator is 50-70°C, and the vacuum degree is -0.08 to -0.10MPa.

8. An antibacterial agent, characterized in that The antibacterial agent comprises the Terminalia chebula extract according to claim 1 or 2 or the Terminalia chebula extract obtained by the preparation method according to any one of claims 3 to 7.

9. A weaned pig feed regulator, characterized in that: The invention comprises the terminalia chebula extract according to claim 1 or 2, the terminalia chebula extract obtained by the preparation method of any one of claims 3 to 7, or the antibacterial agent according to claim 8, wherein the terminalia chebula extract completely replaces zinc oxide in weaned piglet feed.

10. The use according to claim 9, characterized in that: The added amount of the weaned piglet feed regulator is 500-1500 grams per ton.

Citation Information

Patent Citations

  • Fructus terminaliae billericae extract with anti-cancer effect, and preparation method of effective part of fructus terminaliae billericae extract

    CN109453212A

  • Application of myrobalan extract in preparation of malassezia inhibitor

    CN111658683A

  • Terminalia chebula extract as well as preparation method and composition thereof

    CN117045549A

  • Application of fructus terminaliae billericae extract in resisting helicobacter pylori

    CN117045690A

  • Terminalia chebula compositions and method of extracting same

    US20130266676A1